Literature DB >> 22562834

The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism.

Julien Delezie1, Stéphanie Dumont, Hugues Dardente, Hugues Oudart, Aline Gréchez-Cassiau, Paul Klosen, Michèle Teboul, Franck Delaunay, Paul Pévet, Etienne Challet.   

Abstract

Mutations of clock genes can lead to diabetes and obesity. REV-ERBα, a nuclear receptor involved in the circadian clockwork, has been shown to control lipid metabolism. To gain insight into the role of REV-ERBα in energy homeostasis in vivo, we explored daily metabolism of carbohydrates and lipids in chow-fed, unfed, or high-fat-fed Rev-erbα(-/-) mice and their wild-type littermates. Chow-fed Rev-erbα(-/-) mice displayed increased adiposity (2.5-fold) and mild hyperglycemia (∼10%) without insulin resistance. Indirect calorimetry indicates that chow-fed Rev-erbα(-/-) mice utilize more fatty acids during daytime. A 24-h nonfeeding period in Rev-erbα(-/-) animals favors further fatty acid mobilization at the expense of glycogen utilization and gluconeogenesis, without triggering hypoglycemia and hypothermia. High-fat feeding in Rev-erbα(-/-) mice amplified metabolic disturbances, including expression of lipogenic factors. Lipoprotein lipase (Lpl) gene, critical in lipid utilization/storage, is triggered in liver at night and constitutively up-regulated (∼2-fold) in muscle and adipose tissue of Rev-erbα(-/-) mice. We show that CLOCK, up-regulated (2-fold) at night in Rev-erbα(-/-) mice, can transactivate Lpl. Thus, overexpression of Lpl facilitates muscle fatty acid utilization and contributes to fat overload. This study demonstrates the importance of clock-driven Lpl expression in energy balance and highlights circadian disruption as a potential cause for the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562834     DOI: 10.1096/fj.12-208751

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  92 in total

1.  Binding mode prediction and MD/MMPBSA-based free energy ranking for agonists of REV-ERBα/NCoR.

Authors:  Yvonne Westermaier; Sergio Ruiz-Carmona; Isabelle Theret; Françoise Perron-Sierra; Guillaume Poissonnet; Catherine Dacquet; Jean A Boutin; Pierre Ducrot; Xavier Barril
Journal:  J Comput Aided Mol Des       Date:  2017-07-15       Impact factor: 3.686

Review 2.  Nuclear receptor Rev-erbα: up, down, and all around.

Authors:  Logan J Everett; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2014-07-22       Impact factor: 12.015

3.  Regulation of the clock gene expression in human adipose tissue by weight loss.

Authors:  O Pivovarova; Ö Gögebakan; S Sucher; J Groth; V Murahovschi; K Kessler; M Osterhoff; N Rudovich; A Kramer; A F H Pfeiffer
Journal:  Int J Obes (Lond)       Date:  2016-02-23       Impact factor: 5.095

4.  The retinol-binding protein receptor STRA6 regulates diurnal insulin responses.

Authors:  Christy M Gliniak; J Mark Brown; Noa Noy
Journal:  J Biol Chem       Date:  2017-07-21       Impact factor: 5.157

5.  The heme-regulatory motif of nuclear receptor Rev-erbβ is a key mediator of heme and redox signaling in circadian rhythm maintenance and metabolism.

Authors:  Eric L Carter; Yanil Ramirez; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2017-05-12       Impact factor: 5.157

Review 6.  Mechanism of the circadian clock in physiology.

Authors:  Jacob Richards; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-10       Impact factor: 3.619

Review 7.  Clocking In, Working Out: Circadian Regulation of Exercise Physiology.

Authors:  Drew Duglan; Katja A Lamia
Journal:  Trends Endocrinol Metab       Date:  2019-05-02       Impact factor: 12.015

Review 8.  Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.

Authors:  Anand R Saran; Shravan Dave; Amir Zarrinpar
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

9.  Autonomous and self-sustained circadian oscillators displayed in human islet cells.

Authors:  P Pulimeno; T Mannic; D Sage; L Giovannoni; P Salmon; S Lemeille; M Giry-Laterriere; M Unser; D Bosco; C Bauer; J Morf; P Halban; J Philippe; C Dibner
Journal:  Diabetologia       Date:  2012-12-15       Impact factor: 10.122

Review 10.  REV-ERB and ROR nuclear receptors as drug targets.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.